242 related articles for article (PubMed ID: 24275653)
1. Molecular analysis of an alternative N-glycosylation machinery by functional transfer from Actinobacillus pleuropneumoniae to Escherichia coli.
Naegeli A; Neupert C; Fan YY; Lin CW; Poljak K; Papini AM; Schwarz F; Aebi M
J Biol Chem; 2014 Jan; 289(4):2170-9. PubMed ID: 24275653
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic N-glycosyltransferase of Actinobacillus pleuropneumoniae is an inverting enzyme and recognizes the NX(S/T) consensus sequence.
Schwarz F; Fan YY; Schubert M; Aebi M
J Biol Chem; 2011 Oct; 286(40):35267-74. PubMed ID: 21852240
[TBL] [Abstract][Full Text] [Related]
3. Substrate specificity of cytoplasmic N-glycosyltransferase.
Naegeli A; Michaud G; Schubert M; Lin CW; Lizak C; Darbre T; Reymond JL; Aebi M
J Biol Chem; 2014 Aug; 289(35):24521-32. PubMed ID: 24962585
[TBL] [Abstract][Full Text] [Related]
4. The N-linking glycosylation system from Actinobacillus pleuropneumoniae is required for adhesion and has potential use in glycoengineering.
Cuccui J; Terra VS; Bossé JT; Naegeli A; Abouelhadid S; Li Y; Lin CW; Vohra P; Tucker AW; Rycroft AN; Maskell DJ; Aebi M; Langford PR; Wren BW;
Open Biol; 2017 Jan; 7(1):. PubMed ID: 28077594
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic glycoengineering of Apx toxin fragments in the development of Actinobacillus pleuropneumoniae glycoconjugate vaccines.
Passmore IJ; Andrejeva A; Wren BW; Cuccui J
BMC Vet Res; 2019 Jan; 15(1):6. PubMed ID: 30606265
[TBL] [Abstract][Full Text] [Related]
6. Engineered oligosaccharyltransferases with greatly relaxed acceptor-site specificity.
Ollis AA; Zhang S; Fisher AC; DeLisa MP
Nat Chem Biol; 2014 Oct; 10(10):816-22. PubMed ID: 25129029
[TBL] [Abstract][Full Text] [Related]
7. Bacterial N-Glycosylation Efficiency Is Dependent on the Structural Context of Target Sequons.
Silverman JM; Imperiali B
J Biol Chem; 2016 Oct; 291(42):22001-22010. PubMed ID: 27573243
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of the Campylobacter jejuni N-linked protein glycosylation pathway.
Linton D; Dorrell N; Hitchen PG; Amber S; Karlyshev AV; Morris HR; Dell A; Valvano MA; Aebi M; Wren BW
Mol Microbiol; 2005 Mar; 55(6):1695-703. PubMed ID: 15752194
[TBL] [Abstract][Full Text] [Related]
9. N-Glycosyltransferase from Aggregatibacter aphrophilus synthesizes glycopeptides with relaxed nucleotide-activated sugar donor selectivity.
Kong Y; Li J; Hu X; Wang Y; Meng Q; Gu G; Wang PG; Chen M
Carbohydr Res; 2018 Jun; 462():7-12. PubMed ID: 29609090
[TBL] [Abstract][Full Text] [Related]
10. Hijacking bacterial glycosylation for the production of glycoconjugates, from vaccines to humanised glycoproteins.
Cuccui J; Wren B
J Pharm Pharmacol; 2015 Mar; 67(3):338-50. PubMed ID: 25244672
[TBL] [Abstract][Full Text] [Related]
11. Desulfovibrio desulfuricans PglB homolog possesses oligosaccharyltransferase activity with relaxed glycan specificity and distinct protein acceptor sequence requirements.
Ielmini MV; Feldman MF
Glycobiology; 2011 Jun; 21(6):734-42. PubMed ID: 21098514
[TBL] [Abstract][Full Text] [Related]
12. The Actinobacillus pleuropneumoniae HMW1C-like glycosyltransferase mediates N-linked glycosylation of the Haemophilus influenzae HMW1 adhesin.
Choi KJ; Grass S; Paek S; St Geme JW; Yeo HJ
PLoS One; 2010 Dec; 5(12):e15888. PubMed ID: 21209858
[TBL] [Abstract][Full Text] [Related]
13. Exploring a combined Escherichia coli-based glycosylation and in vitro transglycosylation approach for expression of glycosylated interferon alpha.
Prabhu SK; Yang Q; Tong X; Wang LX
Bioorg Med Chem; 2021 Mar; 33():116037. PubMed ID: 33515919
[TBL] [Abstract][Full Text] [Related]
14. Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli.
Feldman MF; Wacker M; Hernandez M; Hitchen PG; Marolda CL; Kowarik M; Morris HR; Dell A; Valvano MA; Aebi M
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):3016-21. PubMed ID: 15703289
[TBL] [Abstract][Full Text] [Related]
15. Tethering an N-Glycosylation Sequon-Containing Peptide Creates a Catalytically Competent Oligosaccharyltransferase Complex.
Matsumoto S; Taguchi Y; Shimada A; Igura M; Kohda D
Biochemistry; 2017 Jan; 56(4):602-611. PubMed ID: 27997792
[TBL] [Abstract][Full Text] [Related]
16. Relaxed acceptor site specificity of bacterial oligosaccharyltransferase in vivo.
Schwarz F; Lizak C; Fan YY; Fleurkens S; Kowarik M; Aebi M
Glycobiology; 2011 Jan; 21(1):45-54. PubMed ID: 20847188
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of N-linking oligosaccharyl transferase enzymes encoded by deep-sea vent proteobacteria.
Mills DC; Jervis AJ; Abouelhadid S; Yates LE; Cuccui J; Linton D; Wren BW
Glycobiology; 2016 Apr; 26(4):398-409. PubMed ID: 26610891
[TBL] [Abstract][Full Text] [Related]
18. An engineered eukaryotic protein glycosylation pathway in Escherichia coli.
Valderrama-Rincon JD; Fisher AC; Merritt JH; Fan YY; Reading CA; Chhiba K; Heiss C; Azadi P; Aebi M; DeLisa MP
Nat Chem Biol; 2012 Mar; 8(5):434-6. PubMed ID: 22446837
[TBL] [Abstract][Full Text] [Related]
19. Structural and mechanistic studies of the N-glycosylation machinery: from lipid-linked oligosaccharide biosynthesis to glycan transfer.
RamÃrez AS; Locher KP
Glycobiology; 2023 Dec; 33(11):861-872. PubMed ID: 37399117
[TBL] [Abstract][Full Text] [Related]
20. GlycoSNAP: A High-Throughput Screening Methodology for Engineering Designer Glycosylation Enzymes.
Ollis AA; Chai Y; DeLisa MP
Methods Mol Biol; 2015; 1321():37-47. PubMed ID: 26082213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
